Neely MD - Search Results

1

Lipid peroxidation in aging brain and Alzheimer's disease.

Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Montine TJ, et al. Among authors: neely md. Free Radic Biol Med. 2002 Sep 1;33(5):620-6. doi: 10.1016/s0891-5849(02)00807-9. Free Radic Biol Med. 2002. PMID: 12208348 Review.

2

The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

Neely MD, Sidell KR, Graham DG, Montine TJ. Neely MD, et al. J Neurochem. 1999 Jun;72(6):2323-33. doi: 10.1046/j.1471-4159.1999.0722323.x. J Neurochem. 1999. PMID: 10349841 Free article.

3

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Bassett CN, et al. Among authors: neely md. Lipids. 1999 Dec;34(12):1273-80. doi: 10.1007/s11745-999-0478-1. Lipids. 1999. PMID: 10652986

4

Cerebrospinal fluid lipoproteins in Alzheimer's disease.

Bassett CN, Montine KS, Neely MD, Swift LL, Montine TJ. Bassett CN, et al. Among authors: neely md. Microsc Res Tech. 2000 Aug 15;50(4):282-6. doi: 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T. Microsc Res Tech. 2000. PMID: 10936881 Review.

5

Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal.

Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS, Amaranth V, Montine TJ. Neely MD, et al. Free Radic Biol Med. 2000 Nov 15;29(10):1028-36. doi: 10.1016/s0891-5849(00)00411-1. Free Radic Biol Med. 2000. PMID: 11084291

6

CSF lipoproteins and Alzheimer's disease.

Neely MD, Montine TJ. Neely MD, et al. J Nutr Health Aging. 2002;6(6):383-91. J Nutr Health Aging. 2002. PMID: 12459889 Review.

7

Synthesis and cellular effects of an intracellularly activated analogue of 4-hydroxynonenal.

Neely MD, Amarnath V, Weitlauf C, Montine TJ. Neely MD, et al. Chem Res Toxicol. 2002 Jan;15(1):40-7. doi: 10.1021/tx010115w. Chem Res Toxicol. 2002. PMID: 11800596

8

Carbonyl toxicology and Alzheimer's disease.

Picklo MJ, Montine TJ, Amarnath V, Neely MD. Picklo MJ, et al. Among authors: neely md. Toxicol Appl Pharmacol. 2002 Nov 1;184(3):187-97. doi: 10.1006/taap.2002.9506. Toxicol Appl Pharmacol. 2002. PMID: 12460747 Review.

9

Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive impairment.

Boutté AM, Neely MD, Bird TD, Montine KS, Montine TJ. Boutté AM, et al. Among authors: neely md. J Alzheimers Dis. 2005 Sep;8(1):1-6. doi: 10.3233/jad-2005-8101. J Alzheimers Dis. 2005. PMID: 16155344

10

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: neely md. J Neuropathol Exp Neurol. 1998 May;57(5):415-25. doi: 10.1097/00005072-199805000-00005. J Neuropathol Exp Neurol. 1998. PMID: 9596412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters